Jiangtong Peng

945 total citations
23 papers, 761 citations indexed

About

Jiangtong Peng is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Jiangtong Peng has authored 23 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Epidemiology. Recurrent topics in Jiangtong Peng's work include interferon and immune responses (2 papers), Cardiovascular Disease and Adiposity (2 papers) and MicroRNA in disease regulation (2 papers). Jiangtong Peng is often cited by papers focused on interferon and immune responses (2 papers), Cardiovascular Disease and Adiposity (2 papers) and MicroRNA in disease regulation (2 papers). Jiangtong Peng collaborates with scholars based in China, United States and Canada. Jiangtong Peng's co-authors include Yutian Li, Kobina Essandoh, Tianqing Peng, Guo‐Chang Fan, Xiaohong Wang, Dongze Qin, Liwang Yang, Yigang Wang, Wei Huang and Xingjiang Mu and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes and Scientific Reports.

In The Last Decade

Jiangtong Peng

23 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiangtong Peng China 15 525 257 146 108 87 23 761
Vidar Beisvåg Norway 17 371 0.7× 120 0.5× 122 0.8× 83 0.8× 96 1.1× 38 757
Zhaoya Liu China 13 306 0.6× 203 0.8× 108 0.7× 85 0.8× 104 1.2× 26 656
Baohua Yang China 15 504 1.0× 193 0.8× 112 0.8× 93 0.9× 81 0.9× 32 815
Ming-Hui Zheng China 16 399 0.8× 175 0.7× 77 0.5× 93 0.9× 67 0.8× 32 684
Haoxiao Zheng China 12 863 1.6× 562 2.2× 201 1.4× 144 1.3× 78 0.9× 23 1.2k
Shenglin Ge China 15 307 0.6× 206 0.8× 86 0.6× 77 0.7× 93 1.1× 38 558
Ke‐Qiong Deng China 16 372 0.7× 112 0.4× 249 1.7× 139 1.3× 164 1.9× 32 787
Tsuyoshi Tabuchi Japan 10 479 0.9× 400 1.6× 129 0.9× 91 0.8× 112 1.3× 11 786
Junmeng Zheng China 13 292 0.6× 165 0.6× 83 0.6× 75 0.7× 77 0.9× 41 616
Junsuk Ko United States 13 269 0.5× 137 0.5× 105 0.7× 57 0.5× 69 0.8× 18 661

Countries citing papers authored by Jiangtong Peng

Since Specialization
Citations

This map shows the geographic impact of Jiangtong Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangtong Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangtong Peng more than expected).

Fields of papers citing papers by Jiangtong Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiangtong Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangtong Peng. The network helps show where Jiangtong Peng may publish in the future.

Co-authorship network of co-authors of Jiangtong Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Jiangtong Peng. A scholar is included among the top collaborators of Jiangtong Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiangtong Peng. Jiangtong Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Miao, Yanli, Yi Zhong, Yutian Li, et al.. (2024). Inhibition of HSP20 ameliorates steatotic liver disease by stimulating ERK2-dependent autophagy. Diabetes. 73(6). 909–925. 2 indexed citations
3.
Du, Meng, Cheng Wang, Bing Liu, et al.. (2022). The role of long noncoding RNA Nron in atherosclerosis development and plaque stability. iScience. 25(3). 103978–103978. 11 indexed citations
4.
Haiqing, He, Jiangtong Peng, Rui‐Hua Xu, et al.. (2021). Overexpression of PDE4D in mouse liver is sufficient to trigger NAFLD and hypertension in a CD36-TGF-β1 pathway: therapeutic role of roflumilast. Pharmacological Research. 175. 106004–106004. 20 indexed citations
5.
Li, Xiaoguang, et al.. (2020). Apatinib attenuates phenotypic switching of arterial smooth muscle cells in vascular remodelling by targeting the PDGF Receptor‐β. Journal of Cellular and Molecular Medicine. 24(17). 10128–10139. 7 indexed citations
6.
Du, Meng, Xiaojing Wang, Yuan Lin, et al.. (2020). Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice. Journal of Hepatology. 73(6). 1333–1346. 29 indexed citations
7.
Peng, Jiangtong, Minglu Liang, Feng Zhu, et al.. (2020). 25-Hydroxycholesterol protects against myocardial ischemia-reperfusion injury via inhibiting PARP activity. International Journal of Biological Sciences. 16(2). 298–308. 24 indexed citations
8.
Li, Yutian, Shan Deng, Xiaohong Wang, et al.. (2020). Sectm1a deficiency aggravates inflammation-triggered cardiac dysfunction through disruption of LXRα signalling in macrophages. Cardiovascular Research. 117(3). 890–902. 16 indexed citations
9.
Deng, Shan, Kobina Essandoh, Xiaohong Wang, et al.. (2020). Tsg101 positively regulates P62-Keap1-Nrf2 pathway to protect hearts against oxidative damage. Redox Biology. 32. 101453–101453. 43 indexed citations
10.
Yang, Kunyu, Yongqiang Zheng, Jiangtong Peng, et al.. (2020). Incidence of Death From Unintentional Injury Among Patients With Cancer in the United States. JAMA Network Open. 3(2). e1921647–e1921647. 28 indexed citations
11.
Li, Yutian, Shan Deng, Jiangtong Peng, et al.. (2019). MicroRNA-223 is essential for maintaining functional β-cell mass during diabetes through inhibiting both FOXO1 and SOX6 pathways. Journal of Biological Chemistry. 294(27). 10438–10448. 47 indexed citations
12.
Li, Jia, Jiangtong Peng, Shengnan Zhao, et al.. (2019). Tussilagone Suppresses Angiogenesis by Inhibiting the VEGFR2 Signaling Pathway. Frontiers in Pharmacology. 10. 764–764. 12 indexed citations
13.
Du, Meng, Xiaojing Wang, Xiaoxiang Mao, et al.. (2019). Absence of Interferon Regulatory Factor 1 Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice. Theranostics. 9(16). 4688–4703. 33 indexed citations
14.
Chen, Jiayuan, Jiangtong Peng, Yongqiang Zheng, et al.. (2019). Primary renal lymphoma: a population-based study in the United States, 1980–2013. Scientific Reports. 9(1). 15125–15125. 22 indexed citations
15.
Huang, Dandan, Xiaoxiang Mao, Jiangtong Peng, et al.. (2019). Role of adipokine zinc-α2-glycoprotein in coronary heart disease. American Journal of Physiology-Endocrinology and Metabolism. 317(6). E1055–E1062. 7 indexed citations
16.
Peng, Jiangtong, Yutian Li, Xiaohong Wang, et al.. (2018). An Hsp20-FBXO4 Axis Regulates Adipocyte Function through Modulating PPARγ Ubiquitination. Cell Reports. 23(12). 3607–3620. 27 indexed citations
17.
Mu, Xingjiang, Xiaohong Wang, Wei Huang, et al.. (2017). Circulating Exosomes Isolated from Septic Mice Induce Cardiovascular Hyperpermeability Through Promoting Podosome Cluster Formation. Shock. 49(4). 429–441. 22 indexed citations
18.
Qin, Dongze, Xiaohong Wang, Yutian Li, et al.. (2016). MicroRNA-223-5p and -3p Cooperatively Suppress Necroptosis in Ischemic/Reperfused Hearts. Journal of Biological Chemistry. 291(38). 20247–20259. 117 indexed citations
19.
Yang, Liwang, Yutian Li, Xiaohong Wang, et al.. (2016). Overexpression of miR-223 Tips the Balance of Pro- and Anti-hypertrophic Signaling Cascades toward Physiologic Cardiac Hypertrophy. Journal of Biological Chemistry. 291(30). 15700–15713. 40 indexed citations
20.
Wang, Xiaohong, Haitao Gu, Wei Huang, et al.. (2016). Hsp20-Mediated Activation of Exosome Biogenesis in Cardiomyocytes Improves Cardiac Function and Angiogenesis in Diabetic Mice. Diabetes. 65(10). 3111–3128. 210 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vidar Beisvåg Breakdown of academic impact, for papers by Zhaoya Liu Breakdown of academic impact, for papers by Baohua Yang Breakdown of academic impact, for papers by Ming-Hui Zheng Breakdown of academic impact, for papers by Haoxiao Zheng Breakdown of academic impact, for papers by Shenglin Ge Breakdown of academic impact, for papers by Ke‐Qiong Deng Breakdown of academic impact, for papers by Tsuyoshi Tabuchi Breakdown of academic impact, for papers by Junmeng Zheng Breakdown of academic impact, for papers by Junsuk Ko
Rankless by CCL
2026